Limitations of neutralizing antibody titers in COVID-19 vaccine efficacy trials and a call for additional correlates of protection. [PDF]
Hwang YH, Min DH, Beom Park W.
europepmc +1 more source
Immunological responses against bovine viral diarrhoea virus types 1 and 2 after administration of a commercial subunit vaccine measured by ELISA and serum neutralisation on serum and milk samples. [PDF]
Montbrau C+5 more
europepmc +1 more source
Opportunities and Challenges in Antibody-Drug Conjugates for Cancer Therapy: A New Era for Cancer Treatment. [PDF]
Buyukgolcigezli I+2 more
europepmc +1 more source
Heme oxygenase-1 modulates CD62E-dependent endothelial cell-monocyte interactions and mitigates HLA-I-induced transplant vasculopathy in mice. [PDF]
Schuster L+8 more
europepmc +1 more source
Large-scale computational modelling of H5 influenza variants against HA1-neutralising antibodies. [PDF]
Ford CT+7 more
europepmc +1 more source
Quantifying antibody binding: techniques and therapeutic implications. [PDF]
Lodge J+7 more
europepmc +1 more source
Intestinal antibody repertoire is altered by diabetes and varies depending on the pathogenesis. [PDF]
Chikazawa M, Minato KI.
europepmc +1 more source
Heterochromatin protein 1 (HP1) of Schistosoma mansoni: non-canonical chromatin landscape and oviposition effects. [PDF]
da Trindade NS+7 more
europepmc +1 more source
Impact of self-reported SARS-CoV-2 antibody positivity on cardiac structure and function: findings from UK Biobank CMR cohort. [PDF]
Liu C+8 more
europepmc +1 more source